Innovative Disinfection Solutions Sterilex's proprietary PerQuat® technology enables highly effective biofilm removal and microorganism eradication, positioning the company as a leader in advanced antimicrobial products suitable for diverse sectors such as healthcare, food processing, and water treatment.

Recent Product Launch The launch of ProvaStep, the UK's first granular dry disinfectant, demonstrates Sterilex's commitment to developing innovative, continuous protection solutions that can appeal to high-traffic environments seeking to minimize cross-contamination.

Sustained Industry Recognition Consistently receiving Top Workplaces awards from Baltimore Sun for multiple consecutive years indicates a strong organizational culture and operational stability, which is attractive to partners and customers seeking reliable collaborations.

Expansion and R&D Focus Investments in expanding chemistry and microbiology labs and hiring talented professionals highlight Sterilex’s focus on innovation, creating opportunities to develop tailored solutions for clients in infection control and environmental remediation markets.

Growing Revenue Potential With annual revenues estimated between $50 million and $100 million, Sterilex presents an attractive opportunity for strategic partnerships or distribution channels aimed at expanding their reach into markets requiring high-level biofilm control and decontamination solutions.